anti-LAG3

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

anti-LAG3

Mar 12, 2025, 11:00 | Drugs

Relatlimab : What Patients Need To Know?

Relatlimab is a novel immunotherapy drug developed by Bristol Myers Squibb (BMS) that targets the…

Dec 17, 2024, 19:57 | Blog

Amol Akhade: What after Immunotherapy?

Amol Akhade, Senior consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals,…

Jun 29, 2024, 14:04 | Insight

Piotr Wysocki: Combination of nivolumab and relatlimab in neoadjuvant setting in resectable NSCLC

Piotr Wysocki recently posted on LinkedIn: "Martin Schuler et al. published results of their phase 2…

All: 3 Posts: 1 - 100

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023